Egalet, which is developing abuse-deterrent oral products for the treatment of pain, raised $50 million by offering 4.2 million shares at $12, the midpoint of the range of $11.00 to $13.00. Egalet plans to list on the NASDAQ under the symbol EGLT. Egalet initially filed confidentially on 9/17/2013. Stifel and JMP Securities acted as lead managers on the deal.
